Your browser doesn't support javascript.
loading
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign.
Nyombayire, Julien; Ingabire, Rosine; Magod, Ben; Mazzei, Amelia; Mazarati, Jean-Baptiste; Noben, Jozef; Katwere, Michael; Parker, Rachel; Nsanzimana, Sabin; Wall, Kristin M; Sayinzoga, Felix; Tichacek, Amanda; Robinson, Cynthia; Hammoud, Niina; Priddy, Frances; Allen, Susan; Karita, Etienne.
Afiliação
  • Nyombayire J; Center for Family Health Research, Kigali, Rwanda.
  • Ingabire R; Center for Family Health Research, Kigali, Rwanda.
  • Magod B; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Mazzei A; Center for Family Health Research, Kigali, Rwanda.
  • Mazarati JB; Department of Pathology, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Noben J; Rwanda Biomedical Center, Kigali, Rwanda.
  • Katwere M; Janssen Global Public Health R&D, Beerse, Belgium.
  • Parker R; Janssen Vaccines and Prevention, Leiden, The Netherlands.
  • Nsanzimana S; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Wall KM; Rwanda Biomedical Center, Kigali, Rwanda.
  • Sayinzoga F; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Tichacek A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Robinson C; Rwanda Biomedical Center, Kigali, Rwanda.
  • Hammoud N; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Priddy F; Janssen Vaccines and Prevention, Leiden, The Netherlands.
  • Allen S; Janssen Vaccines and Prevention, Leiden, The Netherlands.
  • Karita E; Independent Consultant, Wellington, New Zealand.
J Infect Dis ; 227(2): 268-277, 2023 01 11.
Article em En | MEDLINE | ID: mdl-35776140
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Convulsões Febris / Vacinas contra Ebola / Ebolavirus Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Ruanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Convulsões Febris / Vacinas contra Ebola / Ebolavirus Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Ruanda País de publicação: Estados Unidos